Literature DB >> 24700472

Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.

Yanan Cao1, Minghui He2, Zhibo Gao2, Ying Peng1, Yanli Li1, Lin Li2, Weiwei Zhou1, Xiangchun Li2, Xu Zhong1, Yiming Lei2, Tingwei Su1, Hang Wang2, Yiran Jiang1, Lin Yang2, Wei Wei1, Xu Yang2, Xiuli Jiang1, Li Liu2, Juan He1, Junna Ye1, Qing Wei3, Yingrui Li2, Weiqing Wang4, Jun Wang5, Guang Ning6.   

Abstract

Adrenal Cushing's syndrome is caused by excess production of glucocorticoid from adrenocortical tumors and hyperplasias, which leads to metabolic disorders. We performed whole-exome sequencing of 49 blood-tumor pairs and RNA sequencing of 44 tumors from cortisol-producing adrenocortical adenomas (ACAs), adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasias (AIMAHs), and adrenocortical oncocytomas (ADOs). We identified a hotspot in the PRKACA gene with a L205R mutation in 69.2% (27 out of 39) of ACAs and validated in 65.5% of a total of 87 ACAs. Our data revealed that the activating L205R mutation, which locates in the P+1 loop of the protein kinase A (PKA) catalytic subunit, promoted PKA substrate phosphorylation and target gene expression. Moreover, we discovered the recurrently mutated gene DOT1L in AIMAHs and CLASP2 in ADOs. Collectively, these data highlight potentially functional mutated genes in adrenal Cushing's syndrome.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700472     DOI: 10.1126/science.1249480

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  77 in total

Review 1.  Protein kinase A defects and cortisol-producing adrenal tumors.

Authors:  Mihail Zilbermint; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 2.  Genetics of adrenal diseases in 2014: Genetics improves understanding of adrenocortical tumours.

Authors:  Xavier Bertagna
Journal:  Nat Rev Endocrinol       Date:  2014-12-16       Impact factor: 43.330

Review 3.  Insights from exome sequencing for endocrine disorders.

Authors:  Christiaan de Bruin; Andrew Dauber
Journal:  Nat Rev Endocrinol       Date:  2015-05-12       Impact factor: 43.330

4.  Cushing's syndrome mutant PKAL205R exhibits altered substrate specificity.

Authors:  Joshua M Lubner; Kimberly L Dodge-Kafka; Cathrine R Carlson; George M Church; Michael F Chou; Daniel Schwartz
Journal:  FEBS Lett       Date:  2017-02-03       Impact factor: 4.124

Review 5.  Genetics of Adrenocortical Development and Tumors.

Authors:  Maya Lodish
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

Review 6.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

7.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

Review 8.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 9.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

Review 10.  Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Authors:  Morgan K Penny; Isabella Finco; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2016-12-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.